Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder A 6-Week Placebo-Controlled Trial

1999381 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Neuropsychopharmacology

Volume 20, Issue 5, pp. 491-505

Field-Weighted Citation Impact: 14.68